Metabutoxycaine
Chemical compound
Clinical data | |
---|---|
Routes of administration | Dental syringe (as novocaine is administered) |
Pharmacokinetic data | |
Metabolism | Lasts for at least 12 hours after injection. |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C17H28N2O3 |
Molar mass | 308.422 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
| |
(verify) |
Metabutoxycaine, marketed under the trade name Primacaine, is a local anesthetic. It is used in dentistry.[1] It has the U.S. patent number 2,882,296.[2]
References
- ^ Wang HS, Gao MS, Li S (December 2003). "[Application of primacaine in operative dentistry: analysis of clinical results]". Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology (in Chinese). 12 (6): 452, 459. PMID 14966589.
- ^ Raymond O Clinton, Stanley C Laskowski, U.S. patent 2,882,296 (1959 to Sterling Drug Inc).
- v
- t
- e
Local anesthetics (primarily sodium channel blockers) (N01B)
Aminobenzoic | |
---|---|
Benzoic | |
ArCO2- (not para-amino or Ph) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e